Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
A month after US healthcare giant Johnson & Johnson announced that its chief financial officer (CFO) Dominic Caruso was to retire after 12 years in the role and Takeda's finance boss left his job with the Japanese firm, France’s biggest pharma company has said that it is losing its long-standing CFO. 19 April 2018
Novartis’ Vas Narasimhan, who became chief executive of the company on February 1, has now found a replacement for his previous post as head of global drug development (GDD) and chief medical officer, naming John Tsai to the position. 19 April 2018
GlaxoSmithKline today revealed is has appointed Kevin Sin as senior vice president and head of worldwide business development for pharmaceuticals research and development. 18 April 2018
Nordic Nanovector saw its share plunge 9.66% to 4.21 euros as markets opened this mornings, after the Norway-based biotech firm revealed that its chief executive, Luigi Costa, will step down from the post by mutual agreement with the board of directors. 5 April 2018
US gene therapy developer Abeona Therapeutics has lured one of the most experienced names in rare diseases to become its new chief executive. 3 April 2018
Celgene Corp on Monday announced that Scott Smith, president and chief operating officer (COO), is leaving the company effective immediately. 3 April 2018
Menarini, one of Italy’s largest pharma companies and still headed by the founding Aleotti family, has decided to entrust the chairmanship of the company to an external manager coming from a large multinational, Dr Eric Cornut. 29 March 2018
After 19 years with the US healthcare giant Johnson & Johnson (NYSE: JNJ), Dominic Caruso, executive vice president, chief financial officer, has elected to retire in September 2018. 22 March 2018
Christine Roy-Duval has left her role as international clinical investigation director at French pharma major Sanofi’s diabetes unit to join metabolic diseases specialist Valbiotis. 21 March 2018
A couple of additions have been made to the executive team of Orchard Therapeutics, a privately-held clinical-stage biotech based in the UK and USA. 21 March 2018
Swedish biotech firm Karolinska Development's portfolio company Modus Therapeutics, which is focused on sickle cell disease (SCD) and malaria, announces that Dr John Öhd has been appointed to a position as chief medical officer (CMO). 15 March 2018
A year after relinquishing the leadership of the UK’s leading drugmaker, Sir Andrew Witty has been named chief executive of a fast-growing player in the pharmacy benefit manager (PBM) space. 14 March 2018
French biotech company Cellectis announced today that Dr Mathieu Simon is retiring as executive vice president and chief operating officer, effective immediately. 14 March 2018